Every material Form 8-K abrdn Healthcare Opportunities Fund has filed with the SEC since September 12, 2023, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Deloitte & Touche LLP resigned as independent auditor of the Tekla Healthcare Opportunities Fund on September 6, 2023, citing an anticipated independence issue tied to a pending transaction between Tekla Capital Management and abrdn Inc. The Board approved the engagement of KPMG LLP on September 7, 2023 for the fiscal year ending September 30, 2023. The filing states that Deloitte's prior reports contained no adverse opinion or disclaimer and that there were no disagreements or reportable events.
Deloitte & Touche LLP resigned on September 6, 2023, due to an anticipated independence issue
Audit Committee approved Deloitte's resignation on September 7, 2023
KPMG LLP engaged as independent registered public accounting firm for fiscal year ending September 30, 2023
Deloitte's letter to the SEC, dated September 12, 2023, is filed as Exhibit 16.1
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every abrdn Healthcare Opportunities Fund filing is on SEC EDGAR ↗. 8-K briefs of other companies →